Shopping Cart
- Remove All
- Your shopping cart is currently empty
Frunevetmab (NV-02), a felinized monoclonal antibody targeting nerve growth factor (NGF), exhibits a high affinity with a dissociation constant (Kd) of 20 pM and has been demonstrated to effectively mitigate osteoarthritis (OA) pain in cats [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Frunevetmab (NV-02), a felinized monoclonal antibody targeting nerve growth factor (NGF), exhibits a high affinity with a dissociation constant (Kd) of 20 pM and has been demonstrated to effectively mitigate osteoarthritis (OA) pain in cats [1] [2]. |
In vitro | Frunevetmab (NV-02) neutralizes nerve growth factor (NGF) with high affinity and potency without binding to the complement system [2]. |
In vivo | Frunevetmab administered subcutaneously at a dosage of 1.0-2.8mg/kg on days 0, 28, and 56 demonstrated a positive therapeutic effect on cats with naturally occurring osteoarthritis, alleviating pain and improving associated mobility impairments and disabilities [1]. |
Alias | NV-02 |
Cas No. | 1708936-80-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.